These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6485248)

  • 1. Antibodies against a tumour-associated antigen in an AKR lymphoma conditioned to grow in BALB/c mice.
    Hajos SE; Alvarez E; Pierangeli S; Pasqualini CD; Margni RA
    Vet Immunol Immunopathol; 1984 Aug; 7(1):53-63. PubMed ID: 6485248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical behaviour of a tumour-associated antigen obtained from an AKR mouse lymphoma.
    Hajos SE; Alvarez E; Pierangeli S; Margni RA; Pasqualini CD
    Vet Immunol Immunopathol; 1985 Jan; 8(1-2):157-69. PubMed ID: 3976168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic differences between AKR lymphoma and thymus cells leading to detection of a tumor antigen associated with immunological enhancement.
    Laguens RP; Colmerauer ME; Segal A; Pasqualini CD
    Int J Cancer; 1978 Jun; 21(6):779-83. PubMed ID: 78915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymectomy does not affect tumour rejection and cytophilic activity in a murine allogeneic lymphoma model.
    Barrera CN; Mazzolli AB; Colmerauer ME; Pasqualini CD
    Allergol Immunopathol (Madr); 1978; 6(5):403-8. PubMed ID: 217260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR; Knight RA
    Nature; 1974 Nov; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of horse and fetal calf serum on the expression of tumor-associated antigen and tumorigenicity of L5178Y leukemia/lymphoma cells.
    Rabinovsky ED; Yang TJ
    Leuk Res; 1986; 10(11):1331-40. PubMed ID: 3796035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of the graft versus host reaction during allogeneic tumour enhancement.
    Piazzon I; Déroche A; Pasqualini CD
    Arch Geschwulstforsch; 1980; 50(4):322-6. PubMed ID: 7458579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing.
    Gomard E; Leclerc JC; Levy JP
    Nature; 1974 Aug; 250(5468):671-3. PubMed ID: 4854374
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immunoadsorbents. An improved technique for specific depletion of cytotoxic (T) lymphoid cells.
    Kedar E; Ortiz de Landazuri M; Bonavida B; Fahey JL
    J Immunol Methods; 1974 May; 5(1):97-102. PubMed ID: 4546233
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumours can act as adjuvants for humoral immunity.
    Brown DM; Fisher TL; Wei C; Frelinger JG; Lord EM
    Immunology; 2001 Apr; 102(4):486-97. PubMed ID: 11328383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the escape of tumor P1798(SC) from immunologic control in hybrid mice (Balb/c X AKR)F1 (BAF1)].
    Ubeira FM; Seoane R; Puentes E; Faro J; Regueiro BJ
    Rev Esp Oncol; 1982; 29(4):711-6. PubMed ID: 6985427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
    Srinivasa Rao V; Bonavida B
    Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological mechanisms in the pathogenesis of virus-induced murine leukemia. II. Characterization of autoreactive thymocytes.
    Proffitt MR; Hirsch MS; McKenzie IF; Gheridian B; Black PH
    Int J Cancer; 1975 Feb; 15(2):230-40. PubMed ID: 47845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.